3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
6
Carcinoid Tumor
5
Neoplasms
4
Carcinoma
3
Vipoma
2
Neoplasm Metastasis
2
Intestinal Obstruction
2
Carcinoma, Islet Cell
2
Somatostatinoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Inoperable Thymoma
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Malignant Carcinoid Syndrome
1
Lymphangiomyoma
1
Lymphangioleiomyomatosis
1
Insulinoma
1
Glucagonoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Gastrinoma
1
Diarrhea
1
Chylous Ascites
1
Chylothorax
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Ascites
1
Adenoma, Islet Cell
1
Interventions
Cisplatin
3
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Radiation
2
Platinum
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cyclophosphamide
2
Congresses as Topic
2
Brachytherapy
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
rocakinogene sifuplasmid
1
durvalumab
1
alovudine
1
adavosertib
1
Vaccines, Synthetic
1
VGX-3100
1
Sonazoid
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
MEDI0457
1
Interleukin-2
1
Immunoglobulin G
1
Fondaparinux
1
Fluorodeoxyglucose F18
1
Fentanyl
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Vaginal Neoplasms
×
Octreotide
×
Clear all
No trials found.